The demonstration that NPM binds to CL in vitro and increases the CL-binding activity of a WB-derived aCL mAb indicates that NPM can interact with CL to form SLE-related immunogenic particles that might be responsible for the concomitant production of anti-NPM and aCL antibodies. This evidence concerns the gene ACLY and systemic lupus erythematosus.